Skip to content
PubMed This is a summary of 11 peer-reviewed journal articles Updated
Pediatric Endocrinology · Central Precocious Puberty

How Are MKRN3 and DLK1 Gene Variants Inherited in CPP?

At a Glance

A father can carry a pathogenic MKRN3 or DLK1 variant without symptoms because the copy he inherited from his mother is usually silenced. When he passes it through sperm, imprinting can activate the copy in a child, giving each child a 50% chance to inherit it.

It can be confusing to learn that your daughter inherited a genetic variant for central precocious puberty (CPP) from her father, especially if neither he nor anyone on his side of the family ever showed signs of early puberty. The reason this happens involves a fascinating genetic process called genomic imprinting. Because of imprinting, men can carry pathogenic (disease-causing) variants in the MKRN3 or DLK1 genes without experiencing symptoms themselves, making them “silent carriers” who can still pass the active trait to their children [1][2].

What is Genomic Imprinting?

Typically, we inherit two copies of every gene: one from our mother and one from our father. For most genes, both copies are active and working in our bodies.

However, MKRN3 and DLK1 are exceptions. They are imprinted genes, which means only one copy is meant to be active, while the other copy receives a chemical mark that typically silences it [3][4].

For both MKRN3 and DLK1, the general rule is that the copy inherited from the mother is silenced, and the copy inherited from the father is active [5][6].

How This Explains Your Husband’s Lack of Symptoms

To understand why your husband didn’t go through early puberty, we look at his “parent of origin” for the gene—meaning who he inherited it from:

  • If he inherited the variant from his mother: His copy of the gene was silenced because it came from a female. The variant was essentially “turned off” in his body, so his puberty happened at a normal time [1][4].
  • When he passes it to his children: Imprinting marks are erased and reset when a person makes eggs or sperm. Because your husband is passing the gene through his sperm, he places a “paternal” (fatherly) mark on it, which tells the child’s body to turn the gene on. If a child inherits this newly active copy, it often triggers CPP [3][6].

This pattern—where the condition appears to hide or skip a generation in the men of the family—is a classic hallmark of maternally imprinted genes [2][7].

Inheritance Risks for Other Children

If a father carries a pathogenic variant in MKRN3 or DLK1, each of his children has a 50% chance of inheriting it. It is important to know that this affects both daughters and sons. If a son inherits the paternally marked gene, the gene will be active, and he is also at risk for early puberty [8][9].

Another Factor: Symptoms Are Easier to Miss in Boys

There is a second scenario: what if the father inherited the variant from his father? In this case, the gene was active in him. Why wouldn’t he remember having early puberty?

Research shows that boys with active MKRN3 variants tend to show the first signs of puberty at a later age than girls do. In clinical studies, girls often show signs around age 6, while boys show signs closer to age 7 or 8 [10][8]. Because puberty before age 9 in boys is still considered medically “precocious,” these boys technically have CPP. However, because their physical changes fall closer to the normal age range and can be subtle, the condition frequently goes undiagnosed in males [7].

What This Means for Your Family

The absence of early puberty in your husband or his relatives does not rule out his side of the family as the source. Understanding this pattern helps map out your family’s health history and identifies who might benefit from cascade testing (testing other family members for a known genetic variant).

Identifying the exact gene also matters because MKRN3 and DLK1 can have different clinical implications. A genetic counselor and pediatric endocrinologist can help you determine the safest monitoring plan for your daughter, evaluate if other young children in the family need to be seen, and ensure any genetic testing is done appropriately [11].

Common questions in this guide

How can a father carry an MKRN3 or DLK1 variant without having early puberty?
If a father inherited the variant from his mother, that copy was usually silenced in his body, so he may have had puberty at a typical age. The imprinting marks are reset when he makes sperm, which can make the variant active when it is passed to a child.
Why can a child have central precocious puberty when the father had no symptoms?
The father may have carried a maternally inherited, silenced copy of the variant. When he passes it through sperm, it receives a paternal imprint, so the child may inherit an active copy and develop central precocious puberty.
What is the chance that another child will inherit the variant?
Each child of a father who carries a pathogenic MKRN3 or DLK1 variant has a 50% chance of inheriting it. This applies to daughters and sons, although inheriting the variant does not by itself replace the need for medical evaluation.
Can boys have MKRN3- or DLK1-related central precocious puberty?
Yes. Boys who inherit an active variant can develop central precocious puberty, but their first signs may appear later and be subtler than in girls. Puberty beginning before age 9 in a boy is considered precocious, even when the changes are easy to overlook.
What genetic testing may be useful for the family?
The family can ask whether the child’s result is classified as pathogenic or likely pathogenic and whether the parent of origin has been confirmed. A genetic counselor can discuss targeted testing for other children and relatives, sometimes called cascade testing.
Could MKRN3 and DLK1 require different follow-up?
They can have different clinical implications, so the specific gene and variant may affect monitoring or treatment discussions. A pediatric endocrinologist and genetic counselor can recommend follow-up based on the child’s result and clinical findings.

Get notified when new evidence is published on Genetic central precocious puberty in female.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (11)
  1. 1

    Molecular analysis of MKRN3 gene in Turkish girls with sporadic and familial idiopathic central precocious puberty.

    Kırkgöz T, Kaygusuz SB, Alavanda C, et al.

    Journal of pediatric endocrinology & metabolism : JPEM 2023; (36(4)):401-408 doi:10.1515/jpem-2022-0645.

    PMID: 36883204
  2. 2

    Novel MKRN3 gene mutation associated with central precocious puberty in a Chinese child: a case report.

    Wang J, Li R, Wang J, et al.

    Frontiers in endocrinology 2024; (15()):1491664 doi:10.3389/fendo.2024.1491664.

    PMID: 39758341
  3. 3

    A case of familial central precocious puberty caused by a novel mutation in the makorin RING finger protein 3 gene.

    Grandone A, Cantelmi G, Cirillo G, et al.

    BMC endocrine disorders 2015; (15()):60 doi:10.1186/s12902-015-0056-8.

    PMID: 26499472
  4. 4

    Paternally Inherited DLK1 Deletion Associated With Familial Central Precocious Puberty.

    Dauber A, Cunha-Silva M, Macedo DB, et al.

    The Journal of clinical endocrinology and metabolism 2017; (102(5)):1557-1567 doi:10.1210/jc.2016-3677.

    PMID: 28324015
  5. 5

    Genetic causes of central precocious puberty.

    Tajima T

    Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology 2022; (31(3)):101-109 doi:10.1297/cpe.2022-0021.

    PMID: 35928377
  6. 6

    Genetics and Epigenetics of Human Pubertal Timing: The Contribution of Genes Associated With Central Precocious Puberty.

    Canton APM, Macedo DB, Abreu AP, Latronico AC

    Journal of the Endocrine Society 2025; (9(2)):bvae228 doi:10.1210/jendso/bvae228.

    PMID: 39839367
  7. 7

    Phenotypic Variability of Males with Loss-of-Function Mutations of <italic>MKRN3</italic>: A Case Report and Literature Review.

    Yamanaka MYM, Montenegro LR, Canton APM, et al.

    Hormone research in paediatrics 2025; 1-10 doi:10.1159/000549607.

    PMID: 41264570
  8. 8

    High Frequency of MKRN3 Mutations in Male Central Precocious Puberty Previously Classified as Idiopathic.

    Bessa DS, Macedo DB, Brito VN, et al.

    Neuroendocrinology 2017; (105(1)):17-25 doi:10.1159/000446963.

    PMID: 27225315
  9. 9

    A new DLK1 defect in a family with idiopathic central precocious puberty: elucidation of the male phenotype.

    Palumbo S, Cirillo G, Sanchez G, et al.

    Journal of endocrinological investigation 2023; (46(6)):1233-1240 doi:10.1007/s40618-022-01997-y.

    PMID: 36577869
  10. 10

    Genotype-Phenotype Correlations in Central Precocious Puberty Caused by MKRN3 Mutations.

    Seraphim CE, Canton APM, Montenegro L, et al.

    The Journal of clinical endocrinology and metabolism 2021; (106(4)):1041-1050 doi:10.1210/clinem/dgaa955.

    PMID: 33383582
  11. 11

    Six Novel Variants in the MKRN3 Gene Causing Central Precocious Puberty.

    Gernay C, Brachet C, Boros E, et al.

    Journal of the Endocrine Society 2022; (7(1)):bvac168 doi:10.1210/jendso/bvac168.

    PMID: 36438546

This page explains how MKRN3 and DLK1 variants may be inherited in central precocious puberty for informational purposes only and does not constitute medical advice. A pediatric endocrinologist and genetic counselor can interpret your family’s results and recommend appropriate testing and monitoring.